Oncogenic Risk of Mycophenolate Mofetil Use in Dermatology Versus Transplant Groups

Name: Oncogenic Risk of Mycophenolate Mofetil Use in Dermatology Versus Transplant Groups
Creator: Robin Yi
Published: 2025-04-14T14:48:31.887Z
Keywords: Dermatology

Yi, Robin; Ruley, Ainsley; Sharma, Aishwarya; Hrin, Matthew; Feldman, Steve; Strowd, Lindsay

doi:10.17632/9mbv8s9kgr.1

Oncogenic Risk of Mycophenolate Mofetil Use in Dermatology Versus Transplant Groups

Published: 14 April 2025| Version 1 | DOI: 10.17632/9mbv8s9kgr.1

Contributors:

Robin Yi, Ainsley Ruley, Aishwarya Sharma, Matthew Hrin, Steve Feldman, Lindsay Strowd

Description

The number of malignant cases that developed after taking MMF for at least 5 years among dermatologic conditions versus transplant patients. The transplant group had statistically higher malignancy cases compared to the dermatologic conditions group (p<0.0001).

Oncogenic Risk of Mycophenolate Mofetil Use in Dermatology Versus Transplant Groups

Description

Files

Categories

Licence